KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
暂无分享,去创建一个
R. Maserati | F. Guerini | M. Clerici | A. Gori | A. Bandera | G. Rizzardini | A. Uglietti | A. Soria | C. Fusco | E. Bolognesi | P. Zucchi
[1] M. Clerici,et al. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy , 2010, AIDS.
[2] Todd M. Allen,et al. Effects of thymic selection of the T cell repertoire on HLA-class I associated control of HIV infection , 2010, Nature.
[3] M. Altfeld,et al. Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. , 2010, AIDS research and human retroviruses.
[4] J. Prieto,et al. Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection , 2009, Journal of Virology.
[5] Jeffrey N. Martin,et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Giulia Marchetti,et al. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] C. Tincati,et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy , 2008, AIDS.
[8] M. John,et al. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] P. Parham,et al. Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL31 , 2008, The Journal of Immunology.
[10] William H. Carr,et al. Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes , 2007, The Journal of experimental medicine.
[11] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[12] Amalio Telenti,et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.
[13] Alison A Motsinger,et al. Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. , 2006, The Journal of infectious diseases.
[14] M. Clerici,et al. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART , 2006, AIDS.
[15] J. Trowsdale,et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. , 2006, American journal of respiratory and critical care medicine.
[16] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[17] S. Moreno,et al. Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[19] P. Kissinger,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.
[20] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[21] C. Tincati,et al. Untangling the immunological implications of nadir on CD4+ cell recovery during suppressive highly active antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] M. Carrington,et al. KIR haplotypes defined by segregation analysis in 59 Centre d’Etude Polymorphisme Humain (CEPH) families , 2008, Immunogenetics.
[23] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[24] D Middleton,et al. New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.
[25] Derek Middleton,et al. New allele frequency database: www.allelefrequencies.net , 2003 .